The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing

Barbara Russell, Sheldon Campbell, Joseph M. Campos, Gerri S. Hall, William D. Lebar, Wallace Greene, Donna Roush, James T. Rudrik, Robert L. Sautter

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Practice guidelines for infectious disease testing at the point of care (POC) have been developed by the National Academy of Clinical Biochemistry. These guidelines were established through extensive review of the scientific literature that addressed infectious disease testing that occurred at the POC. A total of 25 guidelines were established, and in general, it was concluded that (a) rapid tests for group A streptococcal infections provided clinically useful and financially justified results; (b) there was insufficient evidence to recommend POCT for group B Streptococcus screening, however molecular testing is in development as a POC methodology; (c) there were specific and sensitive rapid tests available for Helicobacter pylori testing at POC; (d) rapid tests for influenza viruses should be used for POC testing (POCT) only when the virus is prevalent in the community, and negative results should not be used to rule out influenza virus infections; (e) the currently available human immunodeficiency virus (HIV) rapid tests, under validation conditions, are comparable to the sensitivity and specificity of laboratory-based enzyme-linked immunoassay methods; (f) HIV rapid testing is strongly recommended for source-patient exposures; (g) rapid HIV testing in the peripartum period, laboratory-based or POC, provides information to support antiretroviral prophylaxis and most likely reduce peripartum HIV transmission; and (h) there was fair evidence to support POCT for the presence of Trichomonas vaginalis in the diagnosis of vaginitis. Included are examples of how these guidelines were implemented to successfully change how POCT was being used in physician office laboratories, emergency departments, and hospital clinics at one facility.

Original languageEnglish (US)
Pages (from-to)231-236
Number of pages6
JournalPoint of Care
Volume6
Issue number4
DOIs
StatePublished - Dec 1 2007

Fingerprint

Point-of-Care Systems
Practice Guidelines
Biochemistry
Communicable Diseases
Medicine
HIV
Peripartum Period
Guidelines
Orthomyxoviridae
Vaginitis
Trichomonas vaginalis
Physicians' Offices
Streptococcal Infections
Streptococcus agalactiae
Virus Diseases
Immunoenzyme Techniques
Helicobacter pylori
Hospital Emergency Service
Viruses
Sensitivity and Specificity

Keywords

  • Infectious diseases
  • Near-patient testing
  • Point-of-care testing (POCT)
  • Practice guidelines
  • Rapid testing

ASJC Scopus subject areas

  • Nursing(all)

Cite this

The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing. / Russell, Barbara; Campbell, Sheldon; Campos, Joseph M.; Hall, Gerri S.; Lebar, William D.; Greene, Wallace; Roush, Donna; Rudrik, James T.; Sautter, Robert L.

In: Point of Care, Vol. 6, No. 4, 01.12.2007, p. 231-236.

Research output: Contribution to journalReview article

Russell, B, Campbell, S, Campos, JM, Hall, GS, Lebar, WD, Greene, W, Roush, D, Rudrik, JT & Sautter, RL 2007, 'The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing', Point of Care, vol. 6, no. 4, pp. 231-236. https://doi.org/10.1097/POC.0b013e31809f5fc8
Russell, Barbara ; Campbell, Sheldon ; Campos, Joseph M. ; Hall, Gerri S. ; Lebar, William D. ; Greene, Wallace ; Roush, Donna ; Rudrik, James T. ; Sautter, Robert L. / The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing. In: Point of Care. 2007 ; Vol. 6, No. 4. pp. 231-236.
@article{6584e54f12064fcca9536046de0362cd,
title = "The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing",
abstract = "Practice guidelines for infectious disease testing at the point of care (POC) have been developed by the National Academy of Clinical Biochemistry. These guidelines were established through extensive review of the scientific literature that addressed infectious disease testing that occurred at the POC. A total of 25 guidelines were established, and in general, it was concluded that (a) rapid tests for group A streptococcal infections provided clinically useful and financially justified results; (b) there was insufficient evidence to recommend POCT for group B Streptococcus screening, however molecular testing is in development as a POC methodology; (c) there were specific and sensitive rapid tests available for Helicobacter pylori testing at POC; (d) rapid tests for influenza viruses should be used for POC testing (POCT) only when the virus is prevalent in the community, and negative results should not be used to rule out influenza virus infections; (e) the currently available human immunodeficiency virus (HIV) rapid tests, under validation conditions, are comparable to the sensitivity and specificity of laboratory-based enzyme-linked immunoassay methods; (f) HIV rapid testing is strongly recommended for source-patient exposures; (g) rapid HIV testing in the peripartum period, laboratory-based or POC, provides information to support antiretroviral prophylaxis and most likely reduce peripartum HIV transmission; and (h) there was fair evidence to support POCT for the presence of Trichomonas vaginalis in the diagnosis of vaginitis. Included are examples of how these guidelines were implemented to successfully change how POCT was being used in physician office laboratories, emergency departments, and hospital clinics at one facility.",
keywords = "Infectious diseases, Near-patient testing, Point-of-care testing (POCT), Practice guidelines, Rapid testing",
author = "Barbara Russell and Sheldon Campbell and Campos, {Joseph M.} and Hall, {Gerri S.} and Lebar, {William D.} and Wallace Greene and Donna Roush and Rudrik, {James T.} and Sautter, {Robert L.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1097/POC.0b013e31809f5fc8",
language = "English (US)",
volume = "6",
pages = "231--236",
journal = "Point of Care",
issn = "1533-029X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - The national academy of clinical biochemistry laboratory medicine practice guidelines for point of care infectious disease testing

AU - Russell, Barbara

AU - Campbell, Sheldon

AU - Campos, Joseph M.

AU - Hall, Gerri S.

AU - Lebar, William D.

AU - Greene, Wallace

AU - Roush, Donna

AU - Rudrik, James T.

AU - Sautter, Robert L.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Practice guidelines for infectious disease testing at the point of care (POC) have been developed by the National Academy of Clinical Biochemistry. These guidelines were established through extensive review of the scientific literature that addressed infectious disease testing that occurred at the POC. A total of 25 guidelines were established, and in general, it was concluded that (a) rapid tests for group A streptococcal infections provided clinically useful and financially justified results; (b) there was insufficient evidence to recommend POCT for group B Streptococcus screening, however molecular testing is in development as a POC methodology; (c) there were specific and sensitive rapid tests available for Helicobacter pylori testing at POC; (d) rapid tests for influenza viruses should be used for POC testing (POCT) only when the virus is prevalent in the community, and negative results should not be used to rule out influenza virus infections; (e) the currently available human immunodeficiency virus (HIV) rapid tests, under validation conditions, are comparable to the sensitivity and specificity of laboratory-based enzyme-linked immunoassay methods; (f) HIV rapid testing is strongly recommended for source-patient exposures; (g) rapid HIV testing in the peripartum period, laboratory-based or POC, provides information to support antiretroviral prophylaxis and most likely reduce peripartum HIV transmission; and (h) there was fair evidence to support POCT for the presence of Trichomonas vaginalis in the diagnosis of vaginitis. Included are examples of how these guidelines were implemented to successfully change how POCT was being used in physician office laboratories, emergency departments, and hospital clinics at one facility.

AB - Practice guidelines for infectious disease testing at the point of care (POC) have been developed by the National Academy of Clinical Biochemistry. These guidelines were established through extensive review of the scientific literature that addressed infectious disease testing that occurred at the POC. A total of 25 guidelines were established, and in general, it was concluded that (a) rapid tests for group A streptococcal infections provided clinically useful and financially justified results; (b) there was insufficient evidence to recommend POCT for group B Streptococcus screening, however molecular testing is in development as a POC methodology; (c) there were specific and sensitive rapid tests available for Helicobacter pylori testing at POC; (d) rapid tests for influenza viruses should be used for POC testing (POCT) only when the virus is prevalent in the community, and negative results should not be used to rule out influenza virus infections; (e) the currently available human immunodeficiency virus (HIV) rapid tests, under validation conditions, are comparable to the sensitivity and specificity of laboratory-based enzyme-linked immunoassay methods; (f) HIV rapid testing is strongly recommended for source-patient exposures; (g) rapid HIV testing in the peripartum period, laboratory-based or POC, provides information to support antiretroviral prophylaxis and most likely reduce peripartum HIV transmission; and (h) there was fair evidence to support POCT for the presence of Trichomonas vaginalis in the diagnosis of vaginitis. Included are examples of how these guidelines were implemented to successfully change how POCT was being used in physician office laboratories, emergency departments, and hospital clinics at one facility.

KW - Infectious diseases

KW - Near-patient testing

KW - Point-of-care testing (POCT)

KW - Practice guidelines

KW - Rapid testing

UR - http://www.scopus.com/inward/record.url?scp=37349043622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349043622&partnerID=8YFLogxK

U2 - 10.1097/POC.0b013e31809f5fc8

DO - 10.1097/POC.0b013e31809f5fc8

M3 - Review article

AN - SCOPUS:37349043622

VL - 6

SP - 231

EP - 236

JO - Point of Care

JF - Point of Care

SN - 1533-029X

IS - 4

ER -